COVID-19 vaccines ENABLE the development of deadlier coronavirus variants, warns Nobel Prize winner
French Nobel Prize winner Luc Montagnier recently warned that the proliferation of the Wuhan coronavirus (COVID-19) vaccines actually help facilitate the development of deadlier variants of the coronavirus
Montagnier, 89, won the 2008 Nobel Prize in Medicine for discovering the human immunodeficiency virus, or HIV. He recently discussed the issue of vaccine-borne COVID-19 variants with French journalist and director Pierre Barnerias of Hold-Up Media.
During the interview, Montagnier explained that the COVID-19 vaccines do not stop the virus. In fact, he argued the opposite. He believes they "feed the virus" and help it to develop variants that are more transmissible and more resistant to medications. (Related: SHOCKER: The COVID-19 vaccine itself is creating more VIRULENT variants that may decimate the vaccinated sheeple
Montagnier warned that these virus variants will cause even more severe health complications than the original COVID-19 strain or any of its previous variants.
The Nobel laureate then went on to talk about how mass vaccinations are an "unacceptable mistake" and are a "scientific error as well as a medical error." Montagnier said history will prove his assertion correct "because it is the vaccination that is creating the variants."
Montagnier explained that the COVID-19 vaccines create antibodies against the virus. This, in turn, forces the virus to "find another solution" to continue spreading within a person's body. This is how the coronavirus variants are created.
"It is the variants that are a production and result from the vaccination," he said.
"You see it in each country, it's the same," added Montagnier. "The curve of vaccination is followed by the curve of deaths. I'm following this closely and I am doing experiments … with patients who became sick with corona after being vaccinated."
Emergence of new post-vaccine variants prove Montagnier's theory correct
At least two new COVID-19 variants have entered the United States. Medical researchers now believe these two post-vaccine variants could be worse
than the already more transmissible delta variant.
One of the newest variants is the lambda variant. There are already around 1,500 known COVID-19 cases with the post-vaccine lambda variant.
Dr. Gregory Poland, director of the Vaccine Research Group at the Mayo Clinic
, explained that the lambda variant is more dangerous because it is highly infectious and easily transmissible.
Studies also suggest that the lambda variant may be able to render inert the natural immunity of people who experienced COVID-19 infections by neutralizing their COVID-19 antibodies
Poland pointed out that the lambda variant is now responsible for nearly 90 percent of all COVID-19 cases in Peru "and has really started to spread through South America."
The other variant of concern is so new that it still does not have a Greek letter assigned to it: the B.1.621 variant. It was discovered earlier this year in Colombia.
"It recently caused an outbreak in a nursing home in Belgium and killed seven people that were fully vaccinated," said Poland. He is particularly concerned about B.1.621 because it now represents around one percent of all cases in the U.S.
and nine percent of all COVID-19 cases in Miami, Florida.
Current studies into B.1.621 show that it has similar mutations to the beta variant. This concerns health experts because they believe the new variant could have similar immune escape properties.
But this variant is still too new. Its trajectory will depend on how far fully vaccinated individuals can transmit it and how often it can mutate as it passes through people. Still, its immune escape properties could also contribute to future changes.
Learn more about how the COVID-19 vaccines facilitate the development of new and deadlier coronavirus variants by reading the latest articles at Vaccines.news